vs
Side-by-side financial comparison of KAMADA LTD (KMDA) and P10, Inc. (PX). Click either name above to swap in a different company.
P10, Inc. is the larger business by last-quarter revenue ($81.0M vs $47.0M, roughly 1.7× KAMADA LTD). P10, Inc. runs the higher net margin — 11.7% vs 11.3%, a 0.4% gap on every dollar of revenue. On growth, KAMADA LTD posted the faster year-over-year revenue change (12.6% vs -4.7%). Over the past eight quarters, KAMADA LTD's revenue compounded faster (12.0% CAGR vs 10.7%).
Kamada Ltd. is a global biopharmaceutical company specializing in the research, manufacturing, and commercialization of specialty pharmaceuticals derived from human plasma.
P10, Inc. is a global alternative investment management firm that offers a diversified portfolio of investment solutions spanning private equity, private credit, real assets and venture capital. It primarily caters to institutional clients including pension funds, endowments, foundations, and high-net-worth individuals across North America, Europe, and Asia Pacific.
KMDA vs PX — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.0M | $81.0M |
| Net Profit | $5.3M | $9.5M |
| Gross Margin | 42.0% | — |
| Operating Margin | 16.6% | 31.9% |
| Net Margin | 11.3% | 11.7% |
| Revenue YoY | 12.6% | -4.7% |
| Net Profit YoY | 37.1% | 79.0% |
| EPS (diluted) | $0.09 | $0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $81.0M | ||
| Q3 25 | $47.0M | $75.9M | ||
| Q2 25 | $44.8M | $72.7M | ||
| Q1 25 | $44.0M | $67.7M | ||
| Q4 24 | — | $85.0M | ||
| Q3 24 | $41.7M | $74.2M | ||
| Q2 24 | $42.5M | $71.1M | ||
| Q1 24 | $37.7M | $66.1M |
| Q4 25 | — | $9.5M | ||
| Q3 25 | $5.3M | $2.1M | ||
| Q2 25 | $7.4M | $3.4M | ||
| Q1 25 | $4.0M | $4.5M | ||
| Q4 24 | — | $5.3M | ||
| Q3 24 | $3.9M | $1.4M | ||
| Q2 24 | $4.4M | $7.0M | ||
| Q1 24 | $2.4M | $5.0M |
| Q4 25 | — | — | ||
| Q3 25 | 42.0% | — | ||
| Q2 25 | 42.3% | — | ||
| Q1 25 | 47.1% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 41.3% | — | ||
| Q2 24 | 44.6% | — | ||
| Q1 24 | 44.4% | — |
| Q4 25 | — | 31.9% | ||
| Q3 25 | 16.6% | 14.1% | ||
| Q2 25 | 15.8% | 24.4% | ||
| Q1 25 | 17.7% | 16.6% | ||
| Q4 24 | — | 26.9% | ||
| Q3 24 | 12.7% | 11.9% | ||
| Q2 24 | 13.3% | 23.7% | ||
| Q1 24 | 10.7% | 18.3% |
| Q4 25 | — | 11.7% | ||
| Q3 25 | 11.3% | 2.8% | ||
| Q2 25 | 16.5% | 4.7% | ||
| Q1 25 | 9.0% | 6.7% | ||
| Q4 24 | — | 6.2% | ||
| Q3 24 | 9.3% | 1.9% | ||
| Q2 24 | 10.4% | 9.8% | ||
| Q1 24 | 6.3% | 7.6% |
| Q4 25 | — | $0.08 | ||
| Q3 25 | $0.09 | $0.02 | ||
| Q2 25 | $0.13 | $0.03 | ||
| Q1 25 | $0.07 | $0.04 | ||
| Q4 24 | — | $0.05 | ||
| Q3 24 | $0.07 | $0.01 | ||
| Q2 24 | $0.08 | $0.06 | ||
| Q1 24 | $0.04 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $72.0M | $28.2M |
| Total DebtLower is stronger | — | $373.2M |
| Stockholders' EquityBook value | $265.2M | $403.5M |
| Total Assets | $377.2M | $928.3M |
| Debt / EquityLower = less leverage | — | 0.93× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $28.2M | ||
| Q3 25 | $72.0M | $40.0M | ||
| Q2 25 | $66.0M | $33.4M | ||
| Q1 25 | $76.3M | $74.4M | ||
| Q4 24 | — | $67.5M | ||
| Q3 24 | $72.0M | $61.5M | ||
| Q2 24 | $56.5M | $31.2M | ||
| Q1 24 | $48.2M | $29.0M |
| Q4 25 | — | $373.2M | ||
| Q3 25 | — | $393.4M | ||
| Q2 25 | — | $373.0M | ||
| Q1 25 | — | $357.2M | ||
| Q4 24 | — | $319.8M | ||
| Q3 24 | — | $319.4M | ||
| Q2 24 | — | $300.6M | ||
| Q1 24 | — | $314.0M |
| Q4 25 | — | $403.5M | ||
| Q3 25 | $265.2M | $396.8M | ||
| Q2 25 | $260.0M | $388.9M | ||
| Q1 25 | $252.0M | $374.3M | ||
| Q4 24 | — | $386.9M | ||
| Q3 24 | $255.3M | $394.1M | ||
| Q2 24 | $251.2M | $396.9M | ||
| Q1 24 | $251.2M | $400.1M |
| Q4 25 | — | $928.3M | ||
| Q3 25 | $377.2M | $936.0M | ||
| Q2 25 | $368.2M | $932.2M | ||
| Q1 25 | $375.1M | $877.4M | ||
| Q4 24 | — | $869.3M | ||
| Q3 24 | $351.2M | $857.0M | ||
| Q2 24 | $351.0M | $823.2M | ||
| Q1 24 | $343.2M | $832.8M |
| Q4 25 | — | 0.93× | ||
| Q3 25 | — | 0.99× | ||
| Q2 25 | — | 0.96× | ||
| Q1 25 | — | 0.95× | ||
| Q4 24 | — | 0.83× | ||
| Q3 24 | — | 0.81× | ||
| Q2 24 | — | 0.76× | ||
| Q1 24 | — | 0.78× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $10.4M | $23.0M |
| Free Cash FlowOCF − Capex | — | $18.1M |
| FCF MarginFCF / Revenue | — | 22.3% |
| Capex IntensityCapex / Revenue | — | 6.0% |
| Cash ConversionOCF / Net Profit | 1.97× | 2.43× |
| TTM Free Cash FlowTrailing 4 quarters | — | $14.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $23.0M | ||
| Q3 25 | $10.4M | $-8.6M | ||
| Q2 25 | $8.0M | $13.4M | ||
| Q1 25 | $-513.0K | $-4.7M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | $22.2M | $27.5M | ||
| Q2 24 | $14.0M | $34.8M | ||
| Q1 24 | $1.0M | $11.0M |
| Q4 25 | — | $18.1M | ||
| Q3 25 | — | $-9.5M | ||
| Q2 25 | — | $11.6M | ||
| Q1 25 | — | $-6.0M | ||
| Q4 24 | — | $96.6M | ||
| Q3 24 | — | $25.2M | ||
| Q2 24 | — | $33.9M | ||
| Q1 24 | — | $10.7M |
| Q4 25 | — | 22.3% | ||
| Q3 25 | — | -12.6% | ||
| Q2 25 | — | 15.9% | ||
| Q1 25 | — | -8.9% | ||
| Q4 24 | — | 113.6% | ||
| Q3 24 | — | 34.0% | ||
| Q2 24 | — | 47.7% | ||
| Q1 24 | — | 16.2% |
| Q4 25 | — | 6.0% | ||
| Q3 25 | — | 1.2% | ||
| Q2 25 | — | 2.5% | ||
| Q1 25 | — | 1.9% | ||
| Q4 24 | — | 5.2% | ||
| Q3 24 | — | 3.0% | ||
| Q2 24 | — | 1.3% | ||
| Q1 24 | — | 0.4% |
| Q4 25 | — | 2.43× | ||
| Q3 25 | 1.97× | -4.01× | ||
| Q2 25 | 1.09× | 3.96× | ||
| Q1 25 | -0.13× | -1.05× | ||
| Q4 24 | — | 19.12× | ||
| Q3 24 | 5.75× | 19.54× | ||
| Q2 24 | 3.15× | 4.98× | ||
| Q1 24 | 0.43× | 2.18× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
KMDA
Segment breakdown not available.
PX
| Management Fees | $78.1M | 96% |
| Advisory Fees | $1.8M | 2% |
